GSK plc (GSK) paid $1.84 in dividends per share over the trailing twelve months. The 5-year dividend CAGR is -3.77%.
GSK Annual Dividends per Share (Dividend History)
This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency (typically quarterly or semi-annually).
Annual Dividend History List
| Payment Date | Nominal Dividend / Share | Distribution Change |
|---|---|---|
| May 15, 2026 | $0.46 | -3.46% Cut |
| Feb 20, 2026 | $0.48 | +10.27% Hike |
| Nov 14, 2025 | $0.43 | +0.73% Hike |
| Aug 15, 2025 | $0.43 | -1.11% Cut |
| May 16, 2025 | $0.43 | +8.52% Hike |
| Feb 21, 2025 | $0.40 | +2.98% Hike |
| Nov 15, 2024 | $0.39 | +0.88% Hike |
| Aug 16, 2024 | $0.39 | +2.52% Hike |
| May 16, 2024 | $0.38 | -7.36% Cut |
| Feb 22, 2024 | $0.41 | +19.51% Hike |
| Nov 16, 2023 | $0.34 | -5.95% Cut |
| Aug 17, 2023 | $0.36 | +3.96% Hike |
| May 18, 2023 | $0.35 | +1.65% Hike |
| Feb 23, 2023 | $0.34 | +7.81% Hike |
| Nov 17, 2022 | $0.32 | -18.90% Cut |
| Aug 18, 2022 | $0.39 | +11.38% Hike |
| May 19, 2022 | $0.35 | -43.56% Cut |
| Feb 24, 2022 | $0.62 | +18.84% Hike |
| Nov 18, 2021 | $0.52 | -1.63% Cut |
| Aug 19, 2021 | $0.53 | -16.43% Cut |
| May 20, 2021 | $0.64 | +1.39% Hike |
| Feb 18, 2021 | $0.63 | +26.64% Hike |
| Nov 12, 2020 | $0.50 | +1.00% Hike |
| Aug 13, 2020 | $0.49 | +4.03% Hike |
| May 14, 2020 | $0.47 | -21.25% Cut |
| Feb 20, 2020 | $0.60 | +22.58% Hike |
| Nov 14, 2019 | $0.49 | +2.10% Hike |
| Aug 8, 2019 | $0.48 | -3.24% Cut |
| May 16, 2019 | $0.49 | -17.09% Cut |
| Feb 21, 2019 | $0.60 | +21.59% Hike |
| Nov 15, 2018 | $0.49 | -2.00% Cut |
| Aug 9, 2018 | $0.50 | -5.47% Cut |
| May 10, 2018 | $0.53 | -16.93% Cut |
| Feb 22, 2018 | $0.64 | +26.66% Hike |
| Nov 9, 2017 | $0.50 | +1.55% Hike |
| Aug 9, 2017 | $0.50 | +1.64% Hike |
| May 10, 2017 | $0.49 | -15.28% Cut |
| Feb 22, 2017 | $0.58 | +24.14% Hike |
| Nov 2, 2016 | $0.46 | -7.01% Cut |
| Aug 10, 2016 | $0.50 | -9.93% Cut |
| May 11, 2016 | $0.55 | -55.75% Cut |
| Feb 17, 2016 | $1.25 | +115.12% Hike |
| Nov 10, 2015 | $0.58 | -1.87% Cut |
| Aug 12, 2015 | $0.59 | +2.81% Hike |
| May 13, 2015 | $0.58 | -17.02% Cut |
| Feb 18, 2015 | $0.70 | +13.41% Hike |
| Nov 5, 2014 | $0.61 | -5.43% Cut |
| Aug 6, 2014 | $0.65 | +1.28% Hike |
| May 14, 2014 | $0.64 | -14.62% Cut |
| Feb 19, 2014 | $0.75 | +21.67% Hike |
| Nov 13, 2013 | $0.62 | +11.37% Hike |
| Aug 7, 2013 | $0.55 | +0.55% Hike |
| May 8, 2013 | $0.55 | -20.15% Cut |
| Feb 20, 2013 | $0.69 | +19.00% Hike |
| Nov 14, 2012 | $0.58 | +9.66% Hike |
| Aug 8, 2012 | $0.53 | -3.83% Cut |
| May 9, 2012 | $0.55 | -33.13% Cut |
| Feb 15, 2012 | $0.82 | +51.20% Hike |
| Nov 2, 2011 | $0.54 | +4.22% Hike |
| Aug 3, 2011 | $0.52 | -0.95% Cut |
| May 4, 2011 | $0.53 | -14.47% Cut |
| Feb 9, 2011 | $0.61 | +21.30% Hike |
| Oct 27, 2010 | $0.51 | +10.94% Hike |
| Jul 28, 2010 | $0.46 | -0.65% Cut |
| May 5, 2010 | $0.46 | -19.86% Cut |
| Feb 10, 2010 | $0.57 | +17.14% Hike |
| Nov 4, 2009 | $0.49 | +6.29% Hike |
| Jul 29, 2009 | $0.46 | +12.71% Hike |
| Apr 29, 2009 | $0.41 | -17.37% Cut |
| Feb 11, 2009 | $0.49 | +4.21% Hike |
| Oct 29, 2008 | $0.47 | -8.48% Cut |
| Jul 30, 2008 | $0.52 | — |
| Apr 30, 2008 | $0.52 | -17.22% Cut |
| Feb 13, 2008 | $0.63 | +17.64% Hike |
| Oct 31, 2007 | $0.53 | +7.68% Hike |
| Aug 1, 2007 | $0.49 | +2.91% Hike |
| May 2, 2007 | $0.48 | -12.86% Cut |
| Feb 14, 2007 | $0.55 | +22.39% Hike |
| Nov 1, 2006 | $0.45 | +11.08% Hike |
| Aug 2, 2006 | $0.41 | +3.31% Hike |
| May 10, 2006 | $0.39 | -19.47% Cut |
| Feb 15, 2006 | $0.49 | +37.46% Hike |
| Nov 2, 2005 | $0.35 | +2.01% Hike |
| Aug 3, 2005 | $0.35 | -8.42% Cut |
| May 11, 2005 | $0.38 | -14.41% Cut |
| Feb 16, 2005 | $0.44 | +21.64% Hike |
| Nov 3, 2004 | $0.36 | -0.27% Cut |
| Aug 4, 2004 | $0.37 | +3.68% Hike |
| May 12, 2004 | $0.35 | -33.97% Cut |
| Feb 18, 2004 | $0.53 | +73.21% Hike |
| Oct 29, 2003 | $0.31 | +7.92% Hike |
| Jul 30, 2003 | $0.29 | -9.78% Cut |
| May 7, 2003 | $0.32 | -31.83% Cut |
| Feb 19, 2003 | $0.47 | +50.97% Hike |
| Oct 30, 2002 | $0.31 | -0.96% Cut |
| Jul 31, 2002 | $0.31 | -43.96% Cut |
| May 1, 2002 | $0.56 | -22.38% Cut |
| Feb 20, 2002 | $0.71 | +151.76% Hike |
| Oct 31, 2001 | $0.28 | +0.35% Hike |
| Aug 1, 2001 | $0.28 | -1.39% Cut |
| May 2, 2001 | $0.29 | -61.32% Cut |
| Dec 27, 2000 | $0.74 | +47.81% Hike |
| Aug 9, 2000 | $0.50 | -36.05% Cut |
| Mar 1, 2000 | $0.79 | +45.64% Hike |
| Aug 11, 1999 | $0.54 | -9.41% Cut |
| Mar 3, 1999 | $0.59 | +19.96% Hike |
| Aug 12, 1998 | $0.50 | -23.93% Cut |
| Mar 4, 1998 | $0.65 | +32.79% Hike |
| Aug 13, 1997 | $0.49 | -32.46% Cut |
| Mar 19, 1997 | $0.73 | +52.19% Hike |
| Aug 16, 1996 | $0.48 | -17.64% Cut |
| Mar 22, 1996 | $0.58 | -10.40% Cut |
| Sep 22, 1995 | $0.65 | +97.98% Hike |
| Feb 24, 1995 | $0.33 | -52.96% Cut |
| Sep 23, 1994 | $0.69 | +109.34% Hike |
| Mar 14, 1994 | $0.33 | +472.41% Hike |
| Sep 24, 1993 | $0.06 | -80.98% Cut |
| Mar 5, 1993 | $0.30 | -47.41% Cut |
| Sep 21, 1992 | $0.58 | +106.41% Hike |
| Feb 28, 1992 | $0.28 | -26.73% Cut |
| Sep 16, 1991 | $0.38 | +110.14% Hike |
| Mar 15, 1991 | $0.18 | -42.43% Cut |
| Sep 24, 1990 | $0.32 | +109.93% Hike |
| Mar 30, 1990 | $0.15 | -32.44% Cut |
| Oct 5, 1989 | $0.22 | +136.51% Hike |
| Apr 7, 1989 | $0.09 | +54.92% Hike |
| Nov 18, 1988 | $0.06 | -17.01% Cut |
| Apr 18, 1988 | $0.07 | -48.24% Cut |
| Nov 20, 1987 | $0.14 | +238.10% Hike |
| May 15, 1987 | $0.04 | -75.00% Cut |
| Nov 21, 1986 | $0.17 | +170.97% Hike |
| May 8, 1986 | $0.06 | -73.64% Cut |
| Nov 22, 1985 | $0.24 | +186.83% Hike |
| May 9, 1985 | $0.08 | -28.82% Cut |
| Nov 26, 1984 | $0.12 | — |
About GSK plc
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Luke Victor Miels